Skip to main content
SpringerLink
Log in

Strategic Use of Pharmacoeconomic Research in Early Drug Development and Global Pricing

  • Leading Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Bootman JL, Larson LN, McGhan WF, Townsend RJ. Pharmacoeconomic research and clinical trials: concepts and issues. Drug Intelligence and Clinical Pharmacy 23: 693–697, 1989

    CAS  Google Scholar 

  • Burstall ML. Europe aftcr 1992: implications for pharmaceuticals. Health Affairs 10(3): 151–171, 1991

    Article  Google Scholar 

  • Chrischillcs EA. The contributions of epidemiology to pharmacoeconomic research. Drug Information Journal 26: 219–229, 1992

    Article  Google Scholar 

  • Detsky A. Guidelines for economic analysis of pharmaceutical products: a draft document for Ontario and Canada. PharmacoEconomics 3: 354–361, 1993

    Article  PubMed  CAS  Google Scholar 

  • Di Masi JA, Hansen RW. Grabowski HG, Lasagna L. Cost of innovation in the pharmaceutical industry. Journal of Health Economics 10: 235–238, 1991

    Article  Google Scholar 

  • Drummond M. Cost-of-illness studies: a major headache? PharmacoEconomics 2: 1–4, 1992

    Article  PubMed  CAS  Google Scholar 

  • Drummond MF, Teeling-Smilh G, Wells N. Economic evluation in the development of medicincs. Office of Health Economics, London. 1988

    Google Scholar 

  • Eddy DM. What’s going on in Oregon? Journal of the American Medical Associalion 266(3): 417–420, 1991a

    Article  CAS  Google Scholar 

  • Eddy JM. Oregon’s methods: did cosl-effectiveness analysis fail? Journal of the American Medical Association 266(15): 2135–2141, 1991b

    Article  PubMed  CAS  Google Scholar 

  • Fulda TR, Hass SL. Medicaid drug utilisation review under OBRA 1990: current issues and future directions. PharmacoEconomics 2: 363–370, 1993

    Article  Google Scholar 

  • Fuchs VR, Garber AM. The new technology assessment. New England Journal of Medicine 323(10): 673–677, 1990

    Article  PubMed  CAS  Google Scholar 

  • Garber AM. No too high? New England Journal of Medicine 327(23): 1676–1678, 1992

    Article  PubMed  CAS  Google Scholar 

  • Henry D. Economic analysis as an aid to subsidisation: the development of Australian guidelines for pharmaceuticals. PharmacoEconomies 1: 54–67, 1992

    Article  CAS  Google Scholar 

  • Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive docs a technology have to be to warrant adoption and utilization? Tentative guide for using clinical and economic evaluations. Canadian Medical Association Journal 146(4): 473–481, 1992

    PubMed  CAS  Google Scholar 

  • Loomes G, Mackenzie L. The use of QALYs in health care decision making. Social Science and Medicine 28(4): 299–308, 1989

    Article  PubMed  CAS  Google Scholar 

  • Lure BR. Cost-effectiveness analysis. obtacles to standardisation and its use in regulating pharmaceuticals. PharmacoEconomics 3: 1–9, 1993

    Article  Google Scholar 

  • Townsend RJ. Posl-marketing drug research and development. Drug lntelligence and Clinical Pharmacy 21: 134–136, 1987

    CAS  Google Scholar 

  • Weinstein MC, Fineberg HV, Elstein AS, Frazer HS, Neuhauser D, et al. Clinical decision analysis. pp. 1–11, WB Saunders Co., Philadelphia. 1980

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmacoeconomic Research Department, Syntex Development Research, Division of Syntex (USA) Inc., 3401 Hillview Avenue, PO Box 10850, Palo Alto, California, 94304, USA

    Kevan Clemens, Louis P. Garrison Jr & Amy Jones

  2. Pharmacoeconomic Research Department, Syntex Development Research - Europe, Maidenhead, Berkshire, England

    Frances Macdonald

Authors
  1. Kevan Clemens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Louis P. Garrison Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amy Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Frances Macdonald
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clemens, K., Garrison, L.P., Jones, A. et al. Strategic Use of Pharmacoeconomic Research in Early Drug Development and Global Pricing. PharmacoEconomics 4, 315–322 (1993). https://doi.org/10.2165/00019053-199304050-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199304050-00002

Keywords

Search

Navigation